Given that DMD is caused by absence of dystrophin, multiple strategies aiming to restore dystrophin in muscle have been developed and tested both in preclinical experiments and in clinical trials, with variable results (Verhaart & Aartsma‐Rus, 2019). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.